Company Monitoring Page for Alexion

latest headlines for company on cafepharma

Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet
Xconomy
Sat, 08/31/19 - 08:00 pm
Tags:
patents, Alexion, Amgen, biosimilars, USPTO
Alexion shares slide on Amgen patent challenge to top-seller
Biopharma Dive
Fri, 08/30/19 - 01:00 pm
Tags:
Amgen, Alexion, inter partes review, patents, Soliris
Should Amgen Finally Buy Alexion Pharmaceuticals?
Yahoo/Motley Fool
Sun, 08/25/19 - 05:00 pm
Tags:
Amgen, Alexion, M&A
Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer
Investors Business Daily
Sat, 08/24/19 - 11:14 am
Tags:
Amgen, Alexion, M&A
3 Reasons Why Amgen Could Actually Acquire Alexion
Motley Fool
Sat, 08/24/19 - 11:10 am
Tags:
Alexion, Amgen, M&A
Alexion's beating forecasts with Soliris-to-Ultomiris switch. So what's up with its pesky stock price?
Fierce Pharma
Fri, 07/26/19 - 11:05 am
Tags:
Alexion, Soliris, Ultomiris, PNH
Alexion’s Soliris follow-up Ultomiris snares EU approval
Pharmaforum
Sun, 07/7/19 - 11:13 am
Tags:
Alexion, Europe, Ultomiris, Soliris, patents, PNH
Alexion's cash cow Soliris just got fatter as FDA greenlights another blockbuster indication
Endpoints
Fri, 06/28/19 - 12:36 pm
Tags:
Alexion, Soliris, FDA, autoimmune disease, NMOSD
FDA Action Alert: Regeneron, Sanofi, Celgene
BioSpace
Mon, 06/24/19 - 07:27 pm
Tags:
FDA, drug approvals, Acer Therapeutics, Edsivo, Regeneron, Sanofi, Dupixent, Celgene, Revlimid, Alexion, Soliris, Dova Pharmaceuticals, Doptelet, Nabriva Therapeutics, Contepo, Retrophin, Thiola
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Tags:
Merck, Keytruda, Melinta Therapeutics, Amag Pharmaceuticals, Palatin, Acer Therapeutics, Sanofi, Regeneron, Alexion, Pfizer, Roche, Navidea Biopharmaceuticals, Ascendis Pharma, Scholar Rock, Adaptive Biotechnologies, BridgeBio, IPOs, G Medical Innovations, Karuna, Morphic Therapeutics
3 Big Biotechs Hold Growth Potential in Second Half of 2019
Yahoo/Zacks.com
Sat, 06/22/19 - 12:27 pm
Tags:
Alexion, Gilead Sciences, Vertex Pharmaceuticals
FDA fast-tracks Alexion's Ultomiris in 2nd Soliris indication
Fierce Pharma
Fri, 06/21/19 - 11:40 pm
Tags:
Alexion, Ultomiris, FDA, atypical hemolytic uremic syndrome
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
Tags:
FDA, Merck, Zerbaxa, XERIS, Gvoke HypoPen, Keytruda, Amag Pharmaceuticals, Palatin, Vyleesi, Acer Therapeutics, Edsivo, Sanofi, Regeneron, Dupixent, Alexion, Soliris, Retrophin, Thiola, Allergan, Botox
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Tags:
Merck, Keytruda, Sanofi, Regeneron, Dupixent, Alexion, Soliris, FDA, Dova Pharmaceuticals, Retrophin
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
Motley Fool
Sun, 05/19/19 - 04:05 pm
Tags:
Alexion, Ultomiris, AbbVie, Upadacitinib, risankizumab, Aimmune Therapeutics, AR-101, Bluebird Bio, LentiGlobin
Alexion gets off to the races with key Ultomiris, Soliris launches
Fierce Pharma
Mon, 04/29/19 - 10:25 am
Tags:
Alexion, Ultomiris, Soliris, drug launches
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Mon, 04/22/19 - 10:34 am
Tags:
Concert Pharmaceuticals, Horizon Pharma, Edwards Lifesciences, Zimmer Biomet, Genfit, Precision Biosciences, Boston Scientific, AbbVie, Alexion, Bristol-Myers Squibb, Baxter, Biomarin, AtriCure, Biogen, Seattle Genetics, IPOs, earnings
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
Tags:
side effects, adverse events, Pfizer, Roche, Takeda, Eli Lilly, Bristol-Myers Squibb, Gilead Sciences, Alexion, Celgene, International Working Group on Signal Detection and Management in Pharmacovigilance, pharmacovigilance
Jazz Pharma, Lundbeck and Alexion Pay $122 Million to Settle Kickback Allegations
BioSpace
Thu, 04/4/19 - 11:02 pm
Tags:
Jazz Pharma, Lundbeck, Alexion, kickbacks, charity
Alexion chief registers $16.5M in pay after a solid year, with a relatively low 74-to-1 ratio compared to a well paid staff
Endpoints
Tue, 03/26/19 - 10:15 am
Tags:
Alexion, Pharma CEOs, executive pay, Ludwig Hantson

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.